László Gerő

768 total citations
28 papers, 330 citations indexed

About

László Gerő is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, László Gerő has authored 28 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Surgery and 9 papers in Genetics. Recurrent topics in László Gerő's work include Diabetes and associated disorders (8 papers), Pancreatic function and diabetes (8 papers) and Diet and metabolism studies (6 papers). László Gerő is often cited by papers focused on Diabetes and associated disorders (8 papers), Pancreatic function and diabetes (8 papers) and Diet and metabolism studies (6 papers). László Gerő collaborates with scholars based in Hungary, United Kingdom and Germany. László Gerő's co-authors include Péter Kempler, László Romics, Ágnes Vatay, István Karádi, Zoltán Prohászka, Éva Pozsonyi, Laura Horváth, Nóra Hosszúfalusi, Pál Pánczél and Katalin Rajczy and has published in prestigious journals such as Diabetes Care, Diabetologia and Current Diabetes Reports.

In The Last Decade

László Gerő

24 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
László Gerő Hungary 8 194 183 141 59 42 28 330
A. Petrone Italy 12 201 1.0× 221 1.2× 297 2.1× 58 1.0× 64 1.5× 17 434
Araceli Panelo Philippines 6 112 0.6× 68 0.4× 98 0.7× 30 0.5× 14 0.3× 11 221
Sukumar Nagendran United States 8 166 0.9× 198 1.1× 78 0.6× 257 4.4× 53 1.3× 15 514
Steven L. Due Australia 7 151 0.8× 136 0.7× 22 0.2× 117 2.0× 84 2.0× 11 323
Margherita Occhipinti Italy 10 123 0.6× 225 1.2× 92 0.7× 76 1.3× 20 0.5× 16 292
Sylwia Górczyńska-Kosiorz Poland 11 73 0.4× 150 0.8× 95 0.7× 96 1.6× 33 0.8× 36 295
Anita Rogowicz‐Frontczak Poland 11 112 0.6× 55 0.3× 89 0.6× 43 0.7× 29 0.7× 21 304
Lotte Simonsen Denmark 7 183 0.9× 128 0.7× 31 0.2× 89 1.5× 41 1.0× 7 297
Mozhgan Dorkhan Sweden 13 164 0.8× 53 0.3× 93 0.7× 63 1.1× 32 0.8× 22 326
Keith Usiskin United States 5 149 0.8× 25 0.1× 60 0.4× 49 0.8× 30 0.7× 5 267

Countries citing papers authored by László Gerő

Since Specialization
Citations

This map shows the geographic impact of László Gerő's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by László Gerő with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites László Gerő more than expected).

Fields of papers citing papers by László Gerő

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by László Gerő. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by László Gerő. The network helps show where László Gerő may publish in the future.

Co-authorship network of co-authors of László Gerő

This figure shows the co-authorship network connecting the top 25 collaborators of László Gerő. A scholar is included among the top collaborators of László Gerő based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with László Gerő. László Gerő is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gerő, László. (2023). A duális antidiabetikus hatású kombináció, a tirzepatid. 31(1). 39–44. 1 indexed citations
2.
3.
Gerő, László. (2022). Tirzepatide Reduced Significantly the Body Weight in Obese Patients. 16(1). 1 indexed citations
4.
5.
Barkai, László, Tibor Hídvégi, György Jermendy, et al.. (2016). Large increase in the prevalence of self-reported diabetes based on a nationally representative survey in Hungary. Primary care diabetes. 11(2). 107–111. 17 indexed citations
6.
Horváth, Viktor J., Zsuzsanna Putz, F Izbéki, et al.. (2015). Diabetes-Related Dysfunction of the Small Intestine and the Colon: Focus on Motility. Current Diabetes Reports. 15(11). 94–94. 40 indexed citations
7.
Unnikrishnan, AG, Joseph M. Tibaldi, Andrew J. Krentz, et al.. (2009). Practical guidance on intensification of insulin therapy with BIAsp 30: a consensus statement. International Journal of Clinical Practice. 63(11). 1571–1577. 29 indexed citations
8.
9.
Gerő, László. (2006). [Treatment of nephrotic syndrome in the adult].. PubMed. 147(48). 2313–8. 1 indexed citations
10.
Gerő, László. (2004). [Pathogenesis, symptoms and therapy of type-1 diabetes mellitus].. PubMed. 145(46). 2339–43. 1 indexed citations
11.
Hosszúfalusi, Nóra, Ágnes Vatay, Katalin Rajczy, et al.. (2003). Similar Genetic Features and Different Islet Cell Autoantibody Pattern of Latent Autoimmune Diabetes in Adults (LADA) Compared With Adult-Onset Type 1 Diabetes With Rapid Progression. Diabetes Care. 26(2). 452–457. 116 indexed citations
12.
Vargha, P., et al.. (1998). Effect of diet and fluvastatin treatment on the serum lipid profile of kidney transplant, diabetic recipients: a 1-year follow up. Transplant International. 11(7). S65–S68. 10 indexed citations
13.
Vargha, P., et al.. (1998). Effect of diet and fluvastatin treatment on the serum lipid profile of kidney transplant, diabetic recipients: a 1-year follow up. Transplant International. 11(s1). S65–S68. 5 indexed citations
14.
Schrezenmeir, J., László Gerő, Judith Kirchgessner, et al.. (1994). Relation between secretory function and oxygen supply in isolated islet organs.. PubMed. 26(2). 809–13. 10 indexed citations
15.
Winkler, Gábor, et al.. (1987). Growth hormone reserve in diabetes mellitus.. PubMed. 44(2-3). 269–87.
16.
Gerő, László, L Korányi, & Gy. Tamás. (1983). Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).. PubMed. 9(3). 183–7. 7 indexed citations
17.
Minker, E, G Blazsó, Á Végh, & László Gerő. (1983). Neurogenic component in the effect of papaverine, drotaverine and bencyclane.. PubMed. 34(2-3). 247–55. 3 indexed citations
18.
Holló, I., et al.. (1979). Insulin-, Glucagon- and Calcitonin-Induced Early Decrease in Serum Calcium. Hormone and Metabolic Research. 11(1). 72–76. 3 indexed citations
19.
Gerő, László, et al.. (1976). Effect of Acute Changes in Serum Calcium on Glucose Tolerance, Blood Glucose, IRI and Cortisol Levels. Hormone and Metabolic Research. 8(2). 151–152. 3 indexed citations
20.
Gerő, László. (1969). La restauration du Château royal de Budapest et l'aménagement d'un musée. Museum International (Edition Francaise). 22(2). 98–108.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Petrone Breakdown of academic impact, for papers by Araceli Panelo Breakdown of academic impact, for papers by Sukumar Nagendran Breakdown of academic impact, for papers by Steven L. Due Breakdown of academic impact, for papers by Margherita Occhipinti Breakdown of academic impact, for papers by Sylwia Górczyńska-Kosiorz Breakdown of academic impact, for papers by Anita Rogowicz‐Frontczak Breakdown of academic impact, for papers by Lotte Simonsen Breakdown of academic impact, for papers by Mozhgan Dorkhan Breakdown of academic impact, for papers by Keith Usiskin
Rankless by CCL
2026